Testing effectiveness (Phase 2)Study completedNCT03959761
What this trial is testing
Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian Carcinoma
Who this might be right for
Ovarian Cancer
Hospices Civils de Lyon 22